|
CRT's
antibody portfolio currently contains over 400 antibodies
and is regularly updated with new products. A full technical
profile of each antibody is available online and can be
found by searching by antigen or clone name. Our hybridomas
and antibodies are available for licensing in the fields
of research and in vitro diagnostics, and purified antibody
can be supplied for research purposes on a sales basis.
Hard copies of the catalogue are available on request.
Please
note that CRT supplies to distributors only. However, we
are happy to direct researchers to the appropriate commercial
party to obtain antibodies within our portfolio.
For further information about antibodies from CRT or to discuss sales or licensing options, please contact CRT at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
|